Introduction to Gleevec (Imatinib) 100mg
Gleevec (Imatinib) 100mg is a prescription targeted therapy medicine used in the treatment of certain blood cancers and gastrointestinal tumors, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by inhibiting abnormal proteins that drive cancer cell growth.
Imitab® (Imatinib) 100mg is classified under Prescription Medicines, Oncology Medicines, Targeted Therapy, and Anticancer Drugs. It contains Imatinib, a tyrosine kinase inhibitor that blocks cancer cell signaling pathways.
In many markets, Gleevec is available as the original brand containing the same active ingredient Imatinib, offering similar therapeutic effects under medical supervision.
What Is Gleevec (Imatinib) 100mg?
Imatinib is an oral targeted therapy used to treat specific cancers by blocking proteins responsible for tumor growth.
It belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs), which inhibit abnormal cell signaling and prevent cancer progression.
Generic brands such as Imitab® 100mg contain the same active compound and may be prescribed depending on physician recommendation and availability.
Drug Class and Mechanism of Action
How Imatinib Works
- Inhibits BCR-ABL tyrosine kinase
- Blocks cancer cell signaling pathways
- Prevents uncontrolled cell proliferation
These actions help control cancer growth and improve patient outcomes.
How Gleevec Works in the Body
Imatinib targets specific proteins responsible for abnormal growth in cancer cells.
Key Actions of Imatinib
- Blocks BCR-ABL protein activity
- Stops cancer cell multiplication
- Promotes apoptosis (programmed cell death)
Medical Uses of Gleevec (Imatinib) 100mg
Imatinib for Chronic Myeloid Leukemia (CML)
Used as a primary treatment for patients diagnosed with CML.
Potential Benefits
- Controls leukemia progression
- Improves long-term survival
- Reduces abnormal white blood cell counts
Imatinib for Gastrointestinal Stromal Tumors (GIST)
Used in advanced and post-surgical treatment of GIST.
Treatment Benefits
- Shrinks tumors
- Prevents recurrence
- Improves disease control
Who Can Take Imitab® 100mg?
Eligibility Criteria
Patients may be prescribed this medicine if they:
- Are diagnosed with CML or GIST
- Are suitable for targeted therapy
- Have adequate liver and kidney function
Who Should Avoid Gleevec (Imatinib) 100mg
This medicine should NOT be used by:
- Pregnant or breastfeeding women
- Patients with severe liver impairment (unless monitored)
- Individuals allergic to Imatinib
Gleevec (Imatinib) 100mg Dosage and Administration
Standard Dosage Guidelines
- Typically taken once daily
- Taken orally with food and water
- Dose may vary depending on the patient’s condition
Dosage Adjustments
Doctors may adjust dosage based on:
- Liver and kidney function
- Blood test results
- Individual treatment response
Side Effects of Imitab® 100mg
Common Side Effects
- Nausea and vomiting
- Muscle cramps
- Fatigue
- Swelling (edema)
Serious Side Effects
- Liver toxicity
- Severe fluid retention
- Low blood cell counts
- Rare heart-related issues
Patients should contact their doctor if severe symptoms occur.
Storage
Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight.
Frequently Asked Questions (FAQs)
1. What is Imitab® 100mg used for?
It treats chronic myeloid leukemia and gastrointestinal stromal tumors.
2. Is Imatinib chemotherapy?
No, it is a targeted therapy, not traditional chemotherapy.
3. Can it be used long-term?
Yes, under medical supervision, many patients take it long-term.
4. How should I take Imitab® 100mg?
Take it with food and water to reduce stomach irritation.
5. Can pregnant women take Imatinib?
No, it may cause severe harm to the unborn baby.
6. Is Imitab® the same as Gleevec?
Yes, both contain Imatinib and have the same therapeutic effect.
7. Do I need a prescription?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
This content is for educational purposes and should not replace professional medical advice. Always consult a qualified healthcare provider before using any medication.
